Ulcerative colitis is a chronic, inflammatory bowel disease that causes problematic inflammation of the digestive tract. Those who suffer from ulcerative colitis develop ulcers, or sores, in the digestive tract. The disease can be debilitating and may lead to life-threatening complications in severe cases.

There is currently no known cure for ulcerative colitis. However, treatment therapies are available to combat symptoms and improve the quality of life for those with ulcerative colitis.

  • About the Study

    You may qualify for this research study if you:

    • Are a male or female between the ages of 18 and 75
    • Have been diagnosed with ulcerative colitis for at least the last 3 months
    • Have a history of inadequate response or intolerance to:
      infliximab, adalimumab, golimumab, vedolizumab, and/or tofacitinib (Note: If tofacitinib was received in a clinical trial)
  • Study Location

    The Loretto Hospital
    645 S Central Ave
    Chicago, IL

See if you qualify for this study

  • This field is for validation purposes and should be left unchanged.